Two-dimensional echocardiographic evaluation of ventricular asynergy induced by dipyridamole: correlation with thallium scanning

Clinical Cardiology
N FerraraF Rengo

Abstract

Myocardial asynergies detected by two-dimensional echocardiography during intravenous administration of Dipyridamole (0.75 mg/kg) were evaluated in 54 patients referred for angiographic evaluation of chest pain. Technically adequate two-dimensional echocardiograms suitable for analysis were recorded in 42 of 54 (77.7%) patients studied. Thallium-201 myocardial perfusion scintigraphy, during dipyridamole test was performed in the same patients. Thirty of the 42 patients studied showed significant coronary narrowing at cardiac catheterization. Dipyridamole-induced wall motion abnormalities and myocardial perfusion defects were detected, respectively, in 19 (63.3%) and 21 (70%) of 30 patients with significant coronary artery disease. Wall by wall comparison of the distribution of dipyridamole-induced echocardiographic asynergy with reversible thallium-201 (201Tl) perfusion defects demonstrated complete correlation in 42 segments examined. Three segments with perfusion defects at thallium scanning did not show asynergy during the test while two segments showing wall motion abnormalities during dipyridamole infusion did not manifest perfusion defects. Our study demonstrates that two-dimensional echocardiography during dipyridamole t...Continue Reading

References

Jul 1, 1975·The American Journal of Cardiology·B C CoryaM J Black
Aug 1, 1973·Circulation·J J JacobsJ F Phillips
Jul 1, 1974·The American Journal of Cardiology·S Goldstein, J W de Jong
Dec 1, 1983·Journal of the American College of Cardiology·W S RobertsonP W McHenry
Jan 1, 1981·The American Journal of Cardiology·J MorganrothL Meixell

❮ Previous
Next ❯

Citations

Jul 1, 1994·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·M S Verani
Mar 24, 1995·International Journal of Cardiology·N ZafrirE Lubin
Mar 15, 1989·Journal of the American College of Cardiology·C U CatesM P Sandler
Dec 10, 1991·Echocardiography·R Castello, A J Labovitz
Sep 1, 1989·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·R A JosephsonE P Shapiro
Feb 1, 1988·American Heart Journal·A S IskandrianN Auerbach
Mar 9, 1999·Journal of Cardiovascular Pharmacology·N FerraraF Rengo
Jul 1, 1996·Current Problems in Cardiology·S F Nagueh, W A Zoghbi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.